ItHome Hypertension Nifedipine Market Is Finally Realizing Its Untapped Potential – Science In Me

Nifedipine Market Is Finally Realizing Its Untapped Potential – Science In Me

Credits to the 👉🏾Source Link👉🏾 Olivia
Nifedipine Market Is Finally Realizing Its Untapped Potential – Science In Me

Identify Sales forecasts to help your business keep adequate inventory, create an actionable plan with latest edition released by AMA on Global Nifedipine Market to regulate the balance of demand and supply. This intelligence report provides a comprehensive analysis of the Global Nifedipine Market. This includes Investigation of past progress, ongoing market scenarios, and future prospects. Data True to market on the products, strategies and market share of leading companies of this particular market are mentioned. It’s a 360-degree overview of the global market’s competitive landscape. The report further predicts the size and valuation of the global market during the forecast period. Some of the key players profiled in the study are Pfizer (PFE), Bayer (BAYN), Actavis (United States), Teva (Israel), Shyndec (China), Honglin Pharma (China), Qingdao Huanghai Pharmaceutical (China), Yabao (China), Global Pharm (United States) and Huazhong Pharmaceutical Co Ltd (China).

What is Nifedipine?

Nifedipine belongs to a calcium channel blocker that comes under the dihydropyridine subclass. Primary uses of nifedipine are anti-hypertensive and anti-anginal medications. It relaxes the muscles of heart and blood vessels Nifedipine is used to treat hypertension (high blood pressure) and angina (chest pain). Nifedipine tablets come in an extended-release form and sustained released form of the drug. Nifedipine is also available in immediate-release oral capsules. They are also available in a generic drug. Nifedipine is used to lower blood pressure in people with hypertension, also used as part of combination therapy.

Free Sample Report + All Related Graphs & Charts @: https://www.advancemarketanalytics.com/sample-report/29175-global-nifedipine-market

Market Drivers

  • Increasing No Of Hypertension Patient
  • Rising Use In Combination Therapy

 

Market Trend

  • Used As A Second Line Of Treatment In Vasospastic Angina

 

Restraints

  • Problems Like Edema, Allergic Reaction, Low Blood Pressure Or Low Heart Rate, And Liver Damage Found
  • Drug-Drug Reactions Occur With The Following Categories That is Antibiotics, Antifungal Drugs, Antifungal Drugs, Antiviral Drugs
  • Lower Shelf Life

 

Opportunities

  • Availability In Generic Dose Also
  • Growing Government Support

 

Challenges

  • Short-Acting Nifedipine Is No Longer Considered Appropriate
  • Damages The Blood Vessels Of The Brain

Major Market Developments:

In August 2019 Bayer acquires BlueRock Therapeutics to build a leading position in cell therapy. Bayer AG and BlueRock Therapeutics announced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology company focused on developing engineered cell therapies in the fields of neurology, cardiology, and immunology.

In January 2020 granted approval for Bayer application for nifurtimox to treat pediatric patients with Chagas.A new formulation for the weight-adjusted treatment of pediatric Chagas patients age 0-18 targets most vulnerable patient group / Submission based on results of CHICO phase III clinical study of nifurtimox in pediatric patients with Chagas disease as well as pre-clinical data / Fight against Neglected Tropical Diseases part of Bayer’s Sustainability Strategy.
FDA approved following indication for nifedipine , that is Chronic stable angina, Vasospastic angina, and Hypertension. While in April 2019 FDA approved 30mg, 60mg, 90mg strengths tablets.

Increasing no of hypertension patients due to different reasons. The manufacturing companies have strong competition to earn the profit. Top companies, therefore, acquiring small firms to increase the overall business of the company. While mergers are another option to be in the market and catch the profit margins.

Each segment and sub-segment is analyzed in the research report. The competitive landscape of the market has been elaborated by studying a number of factors such as the best manufacturers, prices and revenues. Global Nifedipine Market is accessible to readers in a logical, wise format. Driving and restraining factors are listed in this study report to help you understand the positive and negative aspects in front of your business.

This study mainly helps understand which market segments or Region or Country they should focus in coming years to channelize their efforts and investments to maximize growth and profitability. The report presents the market competitive landscape and a consistent in depth analysis of the major vendor/key players in the market.

Furthermore, the years considered for the study are as follows:

Historical year – 2014-2018

Base year – 2019

Forecast period** – 2019 to 2025 [** unless otherwise stated]

**Moreover, it will also include the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product services of key players.

Enquire for customization in Report @ https://www.advancemarketanalytics.com/enquiry-before-buy/29175-global-nifedipine-market

The regular update in report considering latest influencing factors allows industry participant to receive latest edition with additional chapter / commentary dictating latest scenario, economic slowdown and COVID-19 impact on overall industry. Further it will also provide qualitative information about when industry could come back on track and what possible measures industry players are taking to deal with current situation.

The Global Nifedipine segments and Market Data Break Down are illuminated below:

by Type (Initial dose(30 to 60 mg orally once a day), Maintenance dose (30 to 90 mg orally once a day), Maximum dose (Up to 120 mg/day)), Application (Heart Failure, Raynauds Syndrome, Cephalalgia, Bronchial Asthma, Hypertension, Angina Pectoris Prophylaxis, Angina Pectoris, Primary Pulmonary Hypertension), Availability of dose (10mg, 20mg, 30mg, 60mg, 90mg), Drug Delivery (Nifedipine Controlled-Release Tablets, Nifedipine Extended Action Tablets)

Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa

Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market

 

Read Detailed Index of full Research Study at @ https://www.advancemarketanalytics.com/reports/29175-global-nifedipine-market

Strategic Points Covered in Table of Content of Global Nifedipine Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Nifedipine market

Chapter 2: Exclusive Summary – the basic information of the Nifedipine Market.

Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges of the Nifedipine

Chapter 4: Presenting the Nifedipine Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.

Chapter 5: Displaying the by Type, End User and Region 2013-2018

Chapter 6: Evaluating the leading manufacturers of the Nifedipine market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile

Chapter 7: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions.

Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Buy the Latest Detailed Report @ https://www.advancemarketanalytics.com/buy-now?format=1&report=29175

Key questions answered

  • Who are the Leading key players and what are their Key Business plans in the Global Nifedipine market?
  • What are the key concerns of the five forces analysis of the Global Nifedipine market?
  • What are different prospects and threats faced by the dealers in the Global Nifedipine market?
  • What are the strengths and weaknesses of the key vendors?

 

Customization Service of the Report:-

AMA Research provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Original Source: https://www.marketwatch.com/press-release/changing-market-dynamics-nifedipine-becomes-attractive-again-2020-03-26

About Author:

Advance Market Analytics is Global leaders of Market Research Industry provides the quantified B2B research to Fortune 500 companies on high growth emerging opportunities which will impact more than 80% of worldwide companies’ revenues.

Our Analyst is tracking high growth study with detailed statistical and in-depth analysis of market trends & dynamics that provide a complete overview of the industry. We follow an extensive research methodology coupled with critical insights related industry factors and market forces to generate the best value for our clients. We Provides reliable primary and secondary data sources, our analysts and consultants derive informative and usable data suited for our clients business needs. The research study enable clients to meet varied market objectives a from global footprint expansion to supply chain optimization and from competitor profiling to M&As.

Contact US :

Craig Francis (PR & Marketing Manager)

AMA Research & Media LLP

Unit No. 429, Parsonage Road Edison, NJ

New Jersey USA – 08837

Phone: +1 (206) 317 1218

[email protected]

Connect with us at LinkedIn | Facebook | Twitter



Source Link

related posts

Leave a Comment

This website uses cookies to improve your experience. We will assume you are ok with this, but you can opt-out if you wish. Accept Read More